Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update

Vivani Medical, Inc. (NASDAQ:VANI) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 374,500 shares, an increase of 32.2% from the March 15th total of 283,300 shares. Based on an average trading volume of 100,100 shares, the short-interest ratio is currently 3.7 days. Currently, 1.2% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $4.00 price target on shares of Vivani Medical in a research note on Wednesday.

Vivani Medical Trading Up 1.0 %

VANI stock opened at $1.06 on Friday. The firm has a 50-day moving average price of $1.08 and a 200-day moving average price of $1.19. Vivani Medical has a 12 month low of $0.91 and a 12 month high of $2.09. The stock has a market capitalization of $62.79 million, a P/E ratio of -2.36 and a beta of 2.76.

Vivani Medical (NASDAQ:VANI) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). As a group, equities analysts predict that Vivani Medical will post -0.41 EPS for the current fiscal year.

Insider Transactions at Vivani Medical

In other news, Director Gregg Williams acquired 44,400 shares of the firm’s stock in a transaction that occurred on Monday, April 7th. The shares were acquired at an average cost of $0.99 per share, with a total value of $43,956.00. Following the completion of the purchase, the director now directly owns 4,799,200 shares of the company’s stock, valued at $4,751,208. The trade was a 0.93 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders bought 106,240 shares of company stock valued at $106,060. Company insiders own 44.30% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Wealthedge Investment Advisors LLC bought a new stake in Vivani Medical during the 4th quarter worth $43,000. Jane Street Group LLC bought a new position in Vivani Medical in the fourth quarter valued at about $66,000. Northern Trust Corp boosted its stake in shares of Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after purchasing an additional 11,540 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Vivani Medical by 4.6% during the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after purchasing an additional 15,008 shares during the last quarter. 6.78% of the stock is currently owned by institutional investors.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.